Home

Mark E. Saad, Director: Axsome Therapeutics AXSM Sell · Filed 01/02

Trade details

Type
Insider sale
Amount
$1,029,236.58
Shares · price
6,231 sh · $165.18 a share
Held after
10,002 sh
Trade date
25/12/31
Filed
26/01/02
Days to filing
2 days

Sold 38.4% of holdings

Share of holding sold
38.4%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Mark E. Saad's recent trades

  • Mark E. Saad

    Sell10b5-1 planAxsome Therapeutics

    $5.2M

    Filed 01/02

  • Mark E. Saad

    Planned sale10b5-1 planAxsome Therapeutics

    $6.2M

    Filed 25/12/31

  • Mark E. Saad

    Sell10b5-1 planAxsome Therapeutics

    $1.1M

    Filed 25/09/05

  • Mark E. Saad

    Planned sale10b5-1 planAxsome Therapeutics

    $1.1M

    Filed 25/09/05

  • Mark E. Saad

    Sell10b5-1 planAxsome Therapeutics

    $1M

    Filed 24/09/11